Identification of Protein Targets for the Antidepressant Effects of in Chinese Medicine Using Isobaric Tags for Relative and Absolute Quantitation
Overview
Affiliations
Kai-Xin-San consists of Ginseng Radix, Polygalae Radix, Acori Tatarinowii Rhizoma, and Poria at a ratio of 3:3:2:2. Kai-Xin-San has been widely used for the treatment of emotional disorders in China. However, no studies have identified the key proteins implicated in response to Kai-Xin-San treatment. In this study, rat models of chronic mild stress were established using different stress methods over 28 days. After 14 days of stress stimulation, rats received daily intragastric administrations of 600 mg/kg Kai-Xin-San. The sucrose preference test was used to determine depression-like behavior in rats, while isobaric tags were used for relative and absolute quantitation-based proteomics to identify altered proteins following Kai-Xin-San treatment. Kai-Xin-San treatment for 2 weeks noticeably improved depression-like behaviors in rats with chronic mild stress. We identified 33 differentially expressed proteins: 7 were upregulated and 26 were downregulated. Functional analysis showed that these differentially expressed proteins participate in synaptic plasticity, neurodevelopment, and neurogenesis. Our results indicate that Kai-Xin-San has an important role in regulating the key node proteins in the synaptic signaling network, and are helpful to better understand the mechanism of the antidepressive effects of Kai-Xin-San and to provide objective theoretical support for its clinical application. The study was approved by the Ethics Committee for Animal Research from the Chinese PLA General Hospital (approval No. X5-2016-07) on March 5, 2016.
Huang B, Wu Y, Li C, Tang Q, Zhang Y Chin Herb Med. 2023; 15(2):201-213.
PMID: 37265761 PMC: 10230641. DOI: 10.1016/j.chmed.2022.10.004.
Yang W, Yin H, Wang Y, Wang Y, Li X, Wang C Chin Herb Med. 2023; 15(2):240-250.
PMID: 37265759 PMC: 10230638. DOI: 10.1016/j.chmed.2022.06.012.
What can traditional Chinese medicine do for adult neurogenesis?.
Shen W, Jiang N, Zhou W Front Neurosci. 2023; 17:1158228.
PMID: 37123359 PMC: 10130459. DOI: 10.3389/fnins.2023.1158228.
Wen J, Yang Y, Hao J Front Pharmacol. 2023; 14:1090526.
PMID: 37007031 PMC: 10060561. DOI: 10.3389/fphar.2023.1090526.
Wang Y, Li X, Jing R, Yang W, Wang Y, Wang C Neuropsychiatr Dis Treat. 2022; 18:2485-2496.
PMID: 36345420 PMC: 9636882. DOI: 10.2147/NDT.S377982.